Literature DB >> 25004189

Endpoints in preclinical Alzheimer's disease trials.

Eric M Reiman1, Jessica B Langbaum, Pierre N Tariot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25004189      PMCID： PMC4459723          DOI： 10.4088/JCP.14com09235

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  11 in total

Review 1.  Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

Authors:  S M Mills; J Mallmann; A M Santacruz; A Fuqua; M Carril; P S Aisen; M C Althage; S Belyew; T L Benzinger; W S Brooks; V D Buckles; N J Cairns; D Clifford; A Danek; A M Fagan; M Farlow; N Fox; B Ghetti; A M Goate; D Heinrichs; R Hornbeck; C Jack; M Jucker; W E Klunk; D S Marcus; R N Martins; C M Masters; R Mayeux; E McDade; J C Morris; A Oliver; J M Ringman; M N Rossor; S Salloway; P R Schofield; J Snider; P Snyder; R A Sperling; C Stewart; R G Thomas; C Xiong; R J Bateman
Journal:  Rev Neurol (Paris)       Date:  2013-09-06       Impact factor: 2.607

Review 2.  New applications of disease genetics and pharmacogenetics to drug development.

Authors:  Allen D Roses; Ann M Saunders; Michael W Lutz; Nanyin Zhang; Ahmad R Hariri; Karen E Asin; Donna G Crenshaw; Kumar Budur; Daniel K Burns; Stephen K Brannan
Journal:  Curr Opin Pharmacol       Date:  2014-01-03       Impact factor: 5.547

3.  An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.

Authors:  Jessica B Langbaum; Suzanne B Hendrix; Napatkamon Ayutyanont; Kewei Chen; Adam S Fleisher; Raj C Shah; Lisa L Barnes; David A Bennett; Pierre N Tariot; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2014-04-21       Impact factor: 21.566

Review 4.  Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.

Authors:  Eric M Reiman; Jessica B S Langbaum; Pierre N Tariot
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 5.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Authors:  Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2014-06       Impact factor: 4.384

7.  Using genetics to enable studies on the prevention of Alzheimer's disease.

Authors:  D G Crenshaw; W K Gottschalk; M W Lutz; I Grossman; A M Saunders; J R Burke; K A Welsh-Bohmer; S K Brannan; D K Burns; A D Roses
Journal:  Clin Pharmacol Ther       Date:  2012-11-07       Impact factor: 6.875

8.  Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.

Authors:  John C Morris; Paul S Aisen; Randall J Bateman; Tammie L S Benzinger; Nigel J Cairns; Anne M Fagan; Bernardino Ghetti; Alison M Goate; David M Holtzman; William E Klunk; Eric McDade; Daniel S Marcus; Ralph N Martins; Colin L Masters; Richard Mayeux; Angela Oliver; Kimberly Quaid; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Natalie J Selsor; Reisa A Sperling; Michael W Weiner; Chengjie Xiong; Krista L Moulder; Virginia D Buckles
Journal:  Clin Investig (Lond)       Date:  2012-10-01

9.  The A4 study: stopping AD before symptoms begin?

Authors:  Reisa A Sperling; Dorene M Rentz; Keith A Johnson; Jason Karlawish; Michael Donohue; David P Salmon; Paul Aisen
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

Review 10.  Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.

Authors:  Krista L Moulder; B Joy Snider; Susan L Mills; Virginia D Buckles; Anna M Santacruz; Randall J Bateman; John C Morris
Journal:  Alzheimers Res Ther       Date:  2013-10-17       Impact factor: 6.982
View more
  3 in total

Review 1.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

Review 2.  Anti-dementia medications: current prescriptions in clinical practice and new agents in progress.

Authors:  Florindo Stella; Márcia Radanovic; Paulo Renato Canineu; Vanessa J R de Paula; Orestes V Forlenza
Journal:  Ther Adv Drug Saf       Date:  2015-08

3.  Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study.

Authors:  Ira Shoulson; Shirley Eberly; David Oakes; Elise Kayson; Anne B Young
Journal:  Ann Clin Transl Neurol       Date:  2019-05-01       Impact factor: 4.511
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.